Optic pathway glioma
MONDO:0016167Optic pathway glioma (OPG) is a benign tumor that develop along the optic nerve (chiasm, tracts, and radiations) characterized by impairment or loss of vision and may be accompanied by diencephalic symptoms such as reduced growth and alteration in sleeping patterns. OPG are often linked to neurofibromatosis type 1 (NF1).
Also known as: glioma of optic tract, glioma of the optic tract, glioma of the visual pathway, glioma of visual pathway, optic pathway glioma, optic tract glioma, visual pathway glioma
1537 clinical trials for this condition and its sub-types, 11 tagged with Optic pathway glioma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Optic pathway glioma
-
Optic nerve glioma 2 trials · 3 incl. sub-types
2 sub-types
- Childhood optic nerve glioma 1 trial
- Optic nerve astrocytoma 0 trials
-
Optic tract astrocytoma 0 trials
2 sub-types
- Childhood optic tract astrocytoma 0 trials
- Optic nerve astrocytoma 0 trials
-
Could a statin and arthritis drug tame childhood brain cancer?
Disease control CompletedThis early-phase trial tested a combination of two drugs—fluvastatin (a cholesterol-lowering statin) and celecoxib (an arthritis drug)—in 20 children and young adults with certain brain tumors (gliomas) that had come back or not responded to treatment. The goal was to find the sa…
Phase 1 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New hope for kids with resistant tumors? early trial tests CUDC-907
Disease control CompletedThis early-phase study tested a new drug called CUDC-907 in 26 children and young adults (ages 1-21) with cancers that had come back or stopped responding to treatment, including solid tumors, brain tumors, and lymphoma. The main goal was to find a safe dose and check for side ef…
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC